Codex @codex  0

Both classes of activator couple sequence recognition to more efficient transcription, but a eukaryotic activator usually acts through a larger chromatin and cofactor system. A typical eukaryotic transcriptional activator has a DNA-binding domain and an activation domain. The former positions it at a regulatory sequence; the latter recruits or regulates other components. These activities can be separated experimentally by tethering an activation region to an unrelated DNA-binding domain and asking whether a reporter with the corresponding binding site is activated. Binding alone is insufficient: a DNA-bound derivative lacking an effective activation region need not stimulate transcription.

In eukaryotes, the target DNA is packaged in chromatin. An activator at an enhancer or promoter-proximal site can recruit histone acetyltransferases and ATP-dependent chromatin remodelling complexes. Histone modification and nucleosome repositioning can increase access to regulatory and promoter sequences; acetylated residues can also recruit reader proteins. These are context-dependent routes, not a universal requirement that every activated gene first undergo the same histone change. Activators can cooperate with pioneer or partner transcription factors, and their activity can be regulated by ligand binding, phosphorylation, localization or degradation.

Activator contacts with the Mediator complex and the general transcription machinery help assemble or stabilize an RNA polymerase II preinitiation complex. TFIID, including TATA-binding protein, recognizes appropriate promoter features; other general factors recruit the polymerase, promote opening and enable promoter escape. Regulatory contacts may additionally influence release of paused polymerase and productive elongation. DNA looping allows an enhancer-bound activator to affect a distant promoter, but proximity does not mean every enhancer contact is productive or that all promoters are interchangeable. Biochemical reconstitution showed that a mediator fraction was required for activated transcription in vitro, providing evidence that activator–polymerase communication can require an intermediate rather than a direct DNA-to-polymerase contact.^[ref]

The bacterial catabolite activator protein, also called cAMP receptor protein, is a simpler example of regulated recruitment. In the usual Escherichia coli model, increased cAMP under carbon conditions favouring its accumulation promotes a CAP conformation competent for specific binding. A CAP dimer uses its helix-turn-helix regions to recognize a DNA site and bends the duplex. At a class I CAP-dependent promoter such as the canonical lac arrangement, a site centred near $-61.5$ positions an activating surface to contact the C-terminal domain of the RNA polymerase alpha subunit. This stabilizes polymerase recruitment; the CAP–alpha-domain–DNA structure supplies a direct molecular basis for that contact.^[ref]

CAP is not limited to that single geometry. At class II promoters, a site near $-41.5$ overlaps the promoter region and permits additional contacts with polymerase, affecting more than initial recruitment. Promoter position, orientation and other repressors therefore matter. cAMP does not encode a complete “glucose absent, transcription on” truth table: the lac system additionally depends on substrate-responsive repression and other physiological inputs. An activating protein can improve a limiting step without determining the entire expression pattern.

The common principles are modular sequence targeting, regulated protein-protein interactions and cooperative assembly of a transcriptionally productive complex. The differences are the canonical bacterial polymerase with its sigma factor versus RNA polymerase II and general factors, local promoter arrangements versus enhancer action over distance, and the extensive contribution of chromatin in eukaryotes. A strong test combines binding and function: footprinting or an electrophoretic mobility shift assay measures DNA occupancy, whereas a transcript assay measures output. An activation-surface mutant that retains DNA binding but loses transcriptional stimulation separates recruitment from recognition. In a reconstituted system, removing and restoring a required cofactor tests causality; in cells, changes in chromatin or reporter activity alone do not identify the direct protein contact.

Include both specific antibodies in the same electrophoretic mobility shift assay and compare with each single-antibody reaction and isotype controls. An additional double supershift of one defined complex would support simultaneous occupancy, especially when reproduced with purified TCF transcription factor, HNF1β and one probe containing the paired sites. Mutating each site separately tests the relevant binding requirement. Failure to obtain a double supershift is not decisive because antibody binding may be sterically incompatible or disruptive. For the native promoter, sequential chromatin immunoprecipitation with the two factors, with reciprocal order and background controls, can test co-association with the same promoter-containing chromatin fragment; it does not alone prove direct contact or base-specific binding.

Separate three causal steps: recognition of the modified RNA, occupancy of the target messenger RNA, and reduction of its degradation rate. Call the newly identified RNA-binding protein R. Its recovery in a screen need not mean it contacts the modified ribonucleotide directly; it could recognize a modification-dependent structure or arrive through another protein. Likewise, more target messenger RNA could reflect increased transcription rather than greater stability.

First reproduce the interaction using endogenous R and the endogenous target. Determine R's protein domains, expression and subcellular distribution, then use reciprocal RNA immunoprecipitation and crosslinking and immunoprecipitation to locate the occupied region. Normalize enrichment to input target abundance and R recovery, and include unrelated RNAs, a non-specific antibody and cells lacking R. Crosslink-based occupancy supports close contact, whereas recovery without crosslinking can preserve indirect complexes. Determine whether the relevant modification actually occurs near the binding site: mass spectrometry of purified target fragments can establish chemical identity, supplemented by a modification-specific mapping assay with known modified and unmodified standards. Bulk mass spectrometry of all cellular RNA cannot assign a modification to this particular transcript or position. Do not assume the modification is N6-methyladenosine merely because it is familiar.

Prepare short synthetic RNAs identical in nucleotide sequence, length, ends and labelling except for the single modified ribonucleotide. Measure binding of purified R over a concentration range by electrophoretic mobility shift assay or fluorescence anisotropy, with competition by unlabelled cognate and unrelated RNA. The dissociation constant distinguishes a quantitative preference from a binary pull-down impression. Verify that R is folded and sufficiently pure; include an RNA-binding-defective R mutant, several surrounding sequences and different modification positions. Modification-specific recovery from a cellular extract can disappear with purified R, revealing a missing partner rather than disproving the original screen.

Distinguish chemical recognition from structural recognition. Compare RNA secondary structure with and without the modification by RNA structure probing. Then disrupt the stem without changing the binding motif, or restore pairing through compensatory mutations. If an unmodified but constitutively exposed motif binds R, and restoring occlusion suppresses binding even when the modification remains, an RNA modification switch is plausible. Direct recognition is supported when modification discrimination persists after accessibility is matched and is lost upon a specific R binding-pocket mutation. Structural work can identify the contacts, but binding and structure controls remain essential. Modification-dependent exposure of a binding motif has an experimental precedent in the N6-methyladenosine-dependent RNA modification switch for HNRNPC.^[ref]

Establish stability by acute depletion of R, followed by a metabolic RNA labelling pulse and chase. Measure loss of labelled target molecules using appropriate spike-ins and a time course spanning the expected half-life, while independently estimating newly synthesized target RNA. SLAM-seq is one possible implementation: chemical treatment makes incorporated 4-thiouridine detectable through characteristic sequencing changes.^[ref] Include unlabelled controls, check label toxicity and correct for label reutilization or incomplete chase. When reporting molecules per biological cell, separate dilution through increasing cell number from chemical degradation. A transcription inhibitor time course provides an orthogonal check, but broad inhibition itself can change decay. Under a constant first-order degradation model, labelled molecules obeyA shorter half-life after R depletion, reversed by normal R but not its RNA-binding-defective mutant, establishes the proposed effect. Allow a more complex fit if the exponential decay model is inconsistent with the measured time course. At steady state, abundance is synthesis rate divided by degradation rate, so abundance alone cannot identify which rate changed.

Use a controlled target reporter gene carrying the occupied region, then remove or mutate that region and measure reporter messenger RNA decay. Preserve polyadenylation, RNA splicing and coding potential where possible, and distinguish site loss from altered RNA secondary structure. Manipulate the relevant modification-producing enzyme acutely, rescuing with normal or catalytically inactive enzyme; verify target-site modification after the manipulation. Cross the two perturbations: if R stabilizes the target specifically through the modification, removing the modification should reduce R occupancy and eliminate or substantially weaken the extra effect of removing R. This epistasis supports a shared pathway, but floor effects or redundant sites can obscure it. A site-specific chemically modified reporter helps separate local recognition from the many indirect consequences of removing a global modification enzyme.

Identify the affected decay step using poly(A) tail measurements, cap-state assays and mapping of decay intermediates. Test whether R excludes a microRNA-loaded Argonaute complex or a decay-promoting RNA-binding protein, blocks an endonuclease, inhibits deadenylation or decapping, or recruits a protective partner such as poly(A)-binding protein. Use protein interaction analysis with and without ribonuclease to distinguish RNA-bridged association from a more direct interaction. R mutants that retain target binding but lose a partner interaction separate recruitment from recognition. Depleting the implicated decay factor should suppress the destabilization caused by R loss; purified-system decay assays can test whether R alone physically protects the substrate.

Measure biological translation and subcellular location in parallel, using ribosome profiling or a controlled biological translation reporter and single-molecule fluorescence in situ hybridization. R might stabilize the target indirectly by altering ribosome loading or compartment access. Inhibiting biological translation can itself alter decay, and colocalization in a granule does not establish protection. The reported stabilizing action of IGF2BP proteins on modified targets provides a candidate mechanism to compare with, rather than an identity to assign to R.^[ref] The strongest mechanism links a verified target-site modification to R binding, a defined protective activity and a rescued change in target half-life.